An aging nuclear power plant on the border between Luxembourg and France and growing geopolitical tension are putting nuclear risk back on the agenda. Currently, the only treatment for acute radiation syndrome is symptomatic or palliative. However, a new drug being developed by Luxembourg medical countermeasures firm USIL Therapeutics means in future radiation exposure will no longer be a death sentence.
Founded in 2025, by Belgian entrepreneur Frederic Marin, USIL Therapeutics is an early-stage company based on mature scientific…

![[CITYPNG.COM]White Google Play PlayStore Logo – 1500×1500](https://startupnews.fyi/wp-content/uploads/2025/08/CITYPNG.COMWhite-Google-Play-PlayStore-Logo-1500x1500-1-630x630.png)